2 results
Positive opinionCompleted
Treatment with Venoruton prevents RVO, which is a surrogate outcome of PTS.
Approved WMOCompleted
IV sildenafil is superior to iNO for the treatment of pulmonary hypertension in CDH newborns and should be considered as the drug of first choice in the future